지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.1
- 수록면
- 1 - 7 (7page)
이용수
초록· 키워드
오류제보하기
FOXM1 (Forkhead box M1) is a key regulator of tumorigenesis. Previous studies demonstrated that FOXM1 overexpression was strongly correlated with poor prognosis in various cancers, including hepatocellular carcinoma (HCC). In this study, we examined an association between the gene expression signature of FOXM1 and HCC patient outcome. The co-expressed gene set of FOXM1, which is significantly associated with the prognosis of HCC patients, was identified by analyzing the gene expression profiles of 100 patients with HCC, and this gene set was validated in two independent HCC patient cohorts (n=573). In multivariate analysis, the co-expressed gene set of FOXM1 was the most significant prognostic factor for overall survival in patients with HCC (hazard ratio=1.706, 95% confidence intervals=1.176–2.475, P=0.005). We also analyzed different types of cancer, including pancreatic adenocarcinoma, lung adenocarcinoma, breast carcinoma and bladder urothelial carcinoma, to verify the association between the co-expressed gene set of FOXM1 and patient prognosis, and we found a consistent prognostic significance, regardless of tumor type. Finally, we identified a putative signaling pathway in which miR-34a acts as an upstream regulator of the FOXM1-MYC signaling network; this pathway may be ultimately responsible for the poor prognosis of HCC patients. The prognostic subgroups defined by the gene expression signature of FOXM1 could help predict high-risk patients and may guide selection of the best treatment strategy.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair
BMB Reports
2019 .01
-
Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1
BMB Reports
2018 .01
-
Mitochondrial metabolism in cancer stem cells: a therapeutic target for colon cancer
BMB Reports
2015 .01
-
Hepatocellular carcinoma: old friends and new tricks
Experimental and Molecular Medicine
2020 .12
-
Mitochondrial defect-responsive gene signature in liver-cancer progression
BMB Reports
2015 .01
-
Methylation-sensitive high-resolution melting analysis of the USP44 promoter can detect early-stage hepatocellular carcinoma in blood samples
BMB Reports
2022 .11
-
SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma
BMB Reports
2018 .01
-
3D Structure Analysis Study of Hepatocellular Carcinoma (HCC) Biomarker NACA, NME2, PSMD4 for High Sensitivity HCC Diagnosis Sensor
한국생물공학회 학술대회
2015 .04
-
Combination of Image-guided Intervention and Functional Polymeric Microspheres for Effective Hepatocellular Carcinoma (HCC) Treatment
한국고분자학회 학술대회 연구논문 초록집
2018 .10
-
Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer
Experimental and Molecular Medicine
2017 .01
-
Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer types
Experimental and Molecular Medicine
2022 .07
-
YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior
Experimental and Molecular Medicine
2021 .06
-
Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma
BMB Reports
2018 .01
-
RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinoma
Experimental and Molecular Medicine
2024 .06
-
Prediction of Cancer Prognosis Using Patient-Specific Cancer Driver Gene Information
Journal of KIISE
2024 .06
-
CDKN2 expression is a potential biomarker for T cell exhaustion in hepatocellular carcinoma
BMB Reports
2024 .06
-
Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma
Experimental and Molecular Medicine
2024 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0